PER 0.00% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-9

  1. 2,315 Posts.
    lightbulb Created with Sketch. 11
    A great announcement…

    “Afandin has advised ANP that it has made significant progress in attracting interest in the further development of ATL1101 and is currently in discussions with a number of corporate and investor groups, some of which are currently undertaking due diligence on ATL1101.”

    Certainly is a positive out looking statement. This will be worth tens of millions to ANP sometime over the next 6 months - conclusion should be made and announced well before the 6 month deadline imo

    Also is more firepower for the share price in the not too distant future…. there really is a cocktail of re-rating news surrounding ANP now.

    I wonder how negotiations for tie-in are coming along...


    Good Luck All!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $41.16K 516.9K

Buyers (Bids)

No. Vol. Price($)
1 74175 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 1272 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.